Search Results for “aging” – Page 90 – media

Experimental Drug to Treat Alzheimer Disease

The condition of memory loss is termed as Alzheimer’s disease, affecting more than 5 million people and there is still no definite cure. A research team reported that an experimental drug could treat Alzheimer’s disease by slowing down the process of clear thinking and memory.
- Source: NBCNews
- 692
- August 1, 2018
Alzheimer's disease Researches
Tendyne Mitral Valve Replacement System U.S. Pivotal Trial Started by Abbott

A pivotal clinical study in the U.S. on the Tendyne Transcatheter Mitral Valve Replacement (TMVR) system for treating mitral regurgitation has been commenced by Abbott.
- Source: MPO Mag
- 1,132
- July 31, 2018
Abbott Clinical Trials heart valves medical device
NuVasive gets FDA Approval for Pulse Spinal Surgical Automation Platform

The San Diego-based company NuVasive has announced US-FDA 510(k) clearance for its Pulse spinal surgical automation platform. The platform includes 2D and 3D navigation and smart imaging capabilities, with implemented surgical planning, neuromonitoring, patient-specific rod bending tech and radiation reduction.
- Source: MassDevice
- 193
- July 31, 2018
FDA medical device New Approvals
GlaxoSmithKline will Shut Bangladesh Drug Manufacturing Operations by End 2018

GlaxoSmithKline will be closing its drug manufacturing operations in Bangladesh by the end of this year and will remain only with its healthcare business that produces Sensodyne, Horlicks and Glaxose-D.
- Source: Reuters
- 637
- July 31, 2018
Company Insight GSK Pharma Asia
Bayer Sidelines Essure Concerns as Anecdotal, Legal Claims Build Up

A week post Bayer’s announcement on the withdrawal of Essure, its contraceptive implant from the market by this year-end due to inadequate sales, its clinical safety is questioned as consumer and legal stress builds up concerning complaints of extreme fatigue, pain and bleeding.
- Source: FierceBiotech
- 527
- July 30, 2018
Bayer Company Insight contraceptive device Essure
Fatty Diet and Liver Function Impact Risk of Alzheimers

Risk of Alzheimer's disease increases with reduction in levels of plasmalogens, a class of lipids produced by the liver that constitute cell membranes in the brain, confirms new research presented at the Alzheimer's Association International Conference (AAIC) 2018 by Mitchel A. Kling, MD, an associate professor of Psychiatry in the Perelman School of Medicine at the University of Pennsylvania and the Veterans Affairs Medical Center.
- Source: ScienceDaily
- 690
- July 29, 2018
Alzheimer's disease diet Researches
Synopsys Ranks Medical Records Higher than Credit Card Details

Olli Jarva, Synopsys’s Software Integrity Group managing consultant, opined that hackers find healthcare data of more value than credit card or social security details, referring to the recent ransomware attack on Singapore’s government health database.
- Source: The Verdict
- 753
- July 26, 2018
digital health EHR Researches
Fatty Liver Recovers Speedily After Hepatitis C Cure

A report in Alimentary Pharmacology and Therapeutics revealed that Liver stiffness and liver fat (steatosis) in chronic hepatitis C virus (HCV) infected patients improved considerably post-treatment with direct-acting antivirals (DAAs) resulting in sustained virological response (SVR). A fall in ALT levels and a rise in platelet count was observed six months after SVR.
- Source: WorldHepatitisAlliance
- 1,323
- July 24, 2018
Fatty liver disease hepatitis C Researches
New 3D Color X-Rays to Diagnose Cancer, Heart Disease and More

The first-ever 3D, color X-rays were tested on a human by New Zealand Scientists, using technology that promises to enhance medical diagnostics in oncology, cardiology, neurology and orthopedics.
- Source: Medical Design and Outsourcing
- 1,216
- July 20, 2018
3D medical device New Approvals x-ray
Create Personalized Bone Grafts with SATE

A team of scientists from the New York Stem Cell Foundation (NYSCF) Research Institute has developed a new bone engineering technique named Segmental Additive Tissue Engineering (SATE). With this technique, segments of bone engineered from stem cells fuse together to form large-scale, personalized grafts.
- Source: The Verdict
- 615
- July 20, 2018
Bone Graft Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.